DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

QMSMEDI vs ZOTA: Stock Comparison

QMSMEDI vs ZOTA HEALTH CAREUpdated 17 Aug 26, 4:08 PM ISTNSE & company filings

QMSMEDI shows a higher ROE, a higher ROCE and a higher net margin, while ZOTA HEALTH CARE shows a lower P/E, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

QMSMEDI leads 6; ZOTA leads 5 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

QMSMEDIZOTA

Valuation lens

What price are you paying?

Market CapContext only
—
₹4,270 Cr
P/E RatioZOTA has the lower reading
12.43x
0x ✓
P/B RatioQMSMEDI has the lower reading
1.95x ✓
6.83x
EPSQMSMEDI has the higher reading
₹1.89 ✓
₹-7.39
Book ValueContext only
₹58.93
₹201.01
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
ZOTA has a lower P/E
0x vs 12.43x
P/B Ratio
QMSMEDI has a lower P/B
1.95x vs 6.83x
EPS
QMSMEDI has higher earnings per share
₹1.89 vs ₹-7.39
Revenue Growth (TTM YoY)
ZOTA has faster revenue growth
67.7% vs 0%
Qtr Sales Growth
ZOTA has stronger quarterly sales growth
14.82% vs 0%
Qtr Profit Growth
ZOTA has stronger quarterly profit growth
40.93% vs 0%
ROE
QMSMEDI has a higher ROE
10.46% vs -10.64%
ROCE
QMSMEDI has a higher ROCE
8.9% vs -8.71%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricQMSMEDIZOTA
Sector—Healthcare
Industry—Pharmaceuticals

Price

MetricQMSMEDIZOTA
Live Price₹138.13₹1,231.1
Day Change4.71%1.01%
Volume1.25 L30,294
52-Week High₹140₹1,740
52-Week Low₹98.05₹1,022
Distance from 52W High-1.34%-29.25%

Valuation

MetricQMSMEDIZOTA
Market Cap—₹4,270 Cr
P/E Ratio12.43x0x
P/B Ratio1.95x6.83x
EPS₹1.89₹-7.39
Book Value₹58.93₹201.01
Dividend Yield0%0%

Growth

MetricQMSMEDIZOTA
Revenue Growth (TTM YoY)0%67.7%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%14.82%
Qtr Profit Growth0%40.93%

Profitability & Leverage

MetricQMSMEDIZOTA
ROE10.46%-10.64%
ROCE8.9%-8.71%
Net Margin0%-13.98%
Operating Margin13.3%-11.6%
Debt to Equity0.65x0.04x

Shareholding

As of Sep 2026 • change vs previous quarter
MetricQMSMEDIZOTA
Promoter Holding68.11%49.38%
FII Holding0.41%▲ 0.41 pp6.92%▼ 1 pp
DII Holding1.3%▼ 0.29 pp7.3%▲ 0.55 pp
Public Holding30.17%▼ 0.13 pp36.4%▲ 0.44 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: QMSMEDI and ZOTA HEALTH CARE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.